Key Highlights
- Aidoc’s $150 million funding accelerates CARE™, a clinical-grade foundation model, to transform clinical decisions and impact 100 million patients within three years.
- With partnerships from General Catalyst, Square Peg, NVIDIA’s NVentures, and leading U.S. health systems, Aidoc targets enterprise-scale AI adoption, faster FDA-clearances, and real-world outcome improvements.
- Enterprise aiOS™ platform and open ecosystem strategy poise Aidoc to unify both in-house and third-party AI for measurable, system-wide clinical impact.
CARE™ Foundation Model Redefining Standards in Clinical AI
Aidoc’s CARE™ model—now backed by $150 million in new funding—promises to revolutionize clinical decision-making across 100 million patient journeys by 2028. By leveraging multimodal data and advanced AI, CARE™ enables new FDA-clearable indications up to 20x faster, with a roadmap to cover 90% of clinically relevant diseases, including cancer and cardiovascular conditions. Two CARE™-powered solutions have already received FDA clearance, and CARE™ is set to become the clinical backbone for top U.S. health systems, including Sutter Health and Advocate Health.
Strategic Backing from Industry Leaders Fuels Market Adoption
Aidoc’s latest round, led by General Catalyst and Square Peg, and joined by NVentures (NVIDIA’s VC arm) alongside Hartford HealthCare, Mercy, Sutter Health, and WellSpan Health, pushes the company’s total funding to $370 million. This coalition signals deep industry faith in Aidoc’s clinical AI vision. With high-powered compute from NVIDIA and AWS, Aidoc aims for unparalleled model performance and rapid real-world scalability.
aiOS™: Platformizing the Future of Healthcare AI
The aiOS™ enterprise platform is central to Aidoc’s open ecosystem strategy, now enabling more than 69% of its clients to run non-Aidoc models alongside its own. aiOS™ delivers robust governance, real-time performance insights, and outcome measurement tools—key for responsible, system-wide adoption. The platform’s seamless integration and focus on measurable benchmarks make it the digital infrastructure of choice for major U.S. health systems, unifying disparate AI solutions into a cohesive, outcome-driven framework.
Transforming Clinical Workflows and Physician Experience
Aidoc-powered AI has already analyzed over 200,000 radiology cases within a single health system, slashing diagnosis delays and easing clinician cognitive overload. By automating high-volume image assessments and follow-ups, Aidoc’s platform supports core hospital functions, boosts efficiency, and directly addresses critical pain points like diagnostic errors and physician burnout.
About Aidoc
Aidoc is a global leader in clinical AI, focused on empowering healthcare providers to improve patient outcomes by integrating advanced artificial intelligence into clinical workflows. With the highest number of FDA-cleared solutions in its field, Aidoc’s always-on platform currently supports care for more than 45 million patients annually across over 150 health systems worldwide. Built on its proprietary aiOS™ platform, Aidoc seamlessly embeds real-time intelligence at the point of care, aiming to eliminate preventable care gaps and improve efficiency for clinicians. For more information, visit their official website.
BioNext Market Insights sees Aidoc’s infusion of capital, high-profile partnerships, and focus on open AI ecosystems as a pivotal leap, promising safer diagnoses, faster pathways from innovation to patient benefit, and a scalable model for the global healthcare industry’s digital transformation.
By
